Your browser doesn't support javascript.
loading
Development and characterization of monoclonal antibody against non-structural protein-2 of Chikungunya virus and its application.
Chattopadhyay, Soma; Kumar, Abhishek; Mamidi, Prabhudutta; Nayak, Tapas Kumar; Das, Indrani; Chhatai, Jagamohan; Basantray, Itishree; Bramha, Umarani; Maiti, Prasanta Kumar; Singh, Sujay; Suryawanshi, Amol Ratnakar; Chattopadhyay, Subhasis.
Afiliação
  • Chattopadhyay S; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India. Electronic address: sochat.ils@gmail.com.
  • Kumar A; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Mamidi P; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Nayak TK; School of Biological Sciences, National Institute of Science Education & Research, Bhubaneswar, India.
  • Das I; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Chhatai J; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Basantray I; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Bramha U; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Maiti PK; Imgenex India Pvt. Ltd., Bhubaneswar, India.
  • Singh S; Imgenex India Pvt. Ltd., Bhubaneswar, India.
  • Suryawanshi AR; Institute of Life Sciences, Nalco Square, Bhubaneswar 751023, India.
  • Chattopadhyay S; School of Biological Sciences, National Institute of Science Education & Research, Bhubaneswar, India.
J Virol Methods ; 199: 86-94, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24462973
ABSTRACT
The recent epidemics of Chikungunya viruses (CHIKV) with unprecedented magnitude and unusual clinical severity have raised a great public health concern worldwide, especially due to unavailability of vaccine or specific therapy. This emphasizes the need to understand the biological processes of this virus in details. Although CHIKV associated research has been initiated, the availability of CHIKV specific reagents for in-depth investigation of viral infection and replication are scanty. For Alphavirus replication, non-structural protein 2 (nsP2) is known to play a key regulatory role among all other non-structural proteins. The current study describes the development and characterization of nsP2 specific monoclonal antibody (mAb) against a synthetic peptide of CHIKV. Reactivity and efficacy of this mAb have been demonstrated by ELISA, Western blot, Flow cytometry and Immunofluorescence assay. Time kinetic study confirms that this mAb is highly sensitive to CHIKV-nsP2 as this protein has been detected very early during viral replication in infected cells. Homology analysis of the selected epitope sequence reveals that it is conserved among all the CHIKV strains of different genotypes, while analysis with other Alphavirus sequences shows that none of them are 100% identical to the epitope sequence. Moreover, using the mAb, three isoforms of CHIKV-nsP2 have been detected in 2D blot analysis during infection in mammalian cells. Accordingly, it can be suggested that the mAb reported in this study can be a sensitive and specific tool for experimental investigations of CHIKV replication and infection.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Chikungunya / Proteínas não Estruturais Virais / Anticorpos Monoclonais / Anticorpos Antivirais / Antígenos Virais Tipo de estudo: Diagnostic_studies / Evaluation_studies Limite: Animals Idioma: En Revista: J Virol Methods Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus Chikungunya / Proteínas não Estruturais Virais / Anticorpos Monoclonais / Anticorpos Antivirais / Antígenos Virais Tipo de estudo: Diagnostic_studies / Evaluation_studies Limite: Animals Idioma: En Revista: J Virol Methods Ano de publicação: 2014 Tipo de documento: Article